young-professional-team-discussing-business-plan-i-2022-02-02-21-53-56-utc-scaled-e1657877

Innovative Biosensors, Inc.

business-people-shake-hands-in-the-office-e1655897424318.jpg

More About Us

We Like to Meet Entrepreneurs

While we invest at Series A (generally, when a company is over $2M in revenue), we like to meet founders before they’re raising their Series A – to build a relationship, learn more about the company, and allow them to get to know us. Please do reach out.

ABOUT US

New Markets Team

Mark Grovic

Co-Founder and General Partner

Recent Posts

Dec 5, 2011

1

min read

Innovative Biosensors, Inc.

Signal Transduction Collaboration

Dr. Graham Jack and his colleagues at IBI offer collaborative support in signal transduction studies for a proposal submitted by the...

Nov 30, 2010

1

min read

Innovative Biosensors, Inc.

Innovative Biosensors licenses its BioFlash-E technology to PathSensors, Inc.

November 30, 2010 — Innovative Biosensors agreed to license its BioFlash-E technology for the rapid detection of pathogens in biodefense...

Follow Us On

Status

Realized

Location

Visit

Innovative Biosensors (IBI), based in Rockville, Maryland, is a clinical stage diagnostics company that develops, manufactures, and markets rapid pathogen detection and diagnostic systems comprised of biosensors (a novel cellular based bioluminescent immunoassay) that generate results at previously unseen levels of speed, sensitivity and specificity.